Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Commentary: making tuberculosis treatment available for all

D Maher1, P Nunn

  • 1Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.

Bulletin of the World Health Organization
|July 2, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TB in older people in Asia: why it is important.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021
Same author

Identifying research questions for HIV, tuberculosis, tuberculosis-HIV, malaria, and neglected tropical diseases through the World Health Organization guideline development process: a retrospective analysis, 2008-2018.

Public health·2020
Same author

Clare Pierard puts down her pen.

Public health action·2020
Same author

Identifying factors affecting age at first semen freezing and age at first semen use in Sahiwal bulls.

Veterinary world·2016
Same author

Open access for operational research publications from low- and middle-income countries: who pays?

Public health action·2015
Same author

Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2013

Tuberculosis treatment evolved from sanatorium care to effective ambulatory and domiciliary options. The Directly Observed Treatment, Short-course (DOTS) strategy is now the global standard for tuberculosis control.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Medical History

Background:

  • Tuberculosis (TB) has been a significant global public health challenge for decades.
  • Historically, TB treatment involved sanatoriums, special diets, and lung collapse therapy, with a 50% fatality rate within five years.
  • Sanatorium treatment was costly and inaccessible to most, highlighting the need for more equitable solutions.

Purpose of the Study:

  • To trace the historical evolution of tuberculosis treatment strategies.
  • To highlight the shift from sanatorium-based care to more accessible domiciliary and ambulatory treatments.
  • To introduce the Directly Observed Treatment, Short-course (DOTS) as the current global TB control strategy.

Main Methods:

  • Historical review of tuberculosis treatment modalities.
Keywords:
DiseasesHealthInfectionsPublic HealthTreatmentTuberculosis--prevention and controlWorld

Related Experiment Videos

  • Analysis of treatment efficacy and accessibility over time.
  • Description of the development of combination therapy, intermittent, and short-course regimens.
  • Introduction of the World Health Organization's DOTS strategy.

    • Main Results:

    • Ambulatory treatment in the 1960s proved as effective as sanatorium care, initiating the decline of the sanatorium era.
    • Development of intermittent and short-course regimens improved treatment options.
    • The DOTS strategy emerged as the leading global approach for tuberculosis control.

    Conclusions:

    • The transition to domiciliary and ambulatory TB treatment significantly improved accessibility.
    • Advancements in pharmacotherapy and regimen design have been crucial in TB management.
    • DOTS represents a comprehensive and globally promoted strategy to combat tuberculosis.